Стр. 71 - 2

71
91. Cassino C. Susceptibility patterns of baseline methicillin–resistant Staphylococcus aureus
(MRSA) isolates from a Global Clinical Trial of nosocomial pneumonia (NP) / C.
Cassino, A. Baruch, P. Hogan // Am. J. Respir. Crit. Care Med. – 2009. – Vol. 179. - P.
1739.
92. Centers for Disease Control and Prevention. Guidelines for Preventing Health–Care–
Associated Pneumonia // March 26, 2004. : 53 (RRO3). – P. 1-36.
93. Chastre J. Ventilator-associated pneumonia / J. Chastre, J.Y. Fagon // Am. J. Respir.
Crit. Care Med. - 2002. - Vol. 165. - P. 867-903.
94. Chastre J. Comparison of 8 vs 15 days of antibiotic therapy for ventilator- associated
pneumonia in adults / J. Chastre, M. Wolff, J.Y. Fagon // JAMA. – 2003. – Vol. 290. –
P. 2588-2598.
95. Choileain N.N. Cell response to surgery / N.N. Choileain, P. Redmond // Arch. Surg. –
2006. – Vol. 141. – P. 1132-1140.
96. Clec’h C. Agreement between quantitative cultures of postintubation tracheal aspiration
and plugged telescoping catheter, protected specimen brush, or BAL for the diagnosis of
nosocomial pneumonia / C. Clec’h, F. Jaureguy, L. Hamza [et al.] // Chest. – 2006. – Vol.
130 - P. 956-961.
97. Cohen J. The immunopathogenesis of sepsis / J. Cohen // Nature. – 2002. – Vol. 420. –
P. 885-891.
98. Corssmit E.P.M. Biologic responses to IFN-α administration in humans / E.P.M.
Corssmit, J. de Metz, H. P. Sauerwein [et al.] // Journal of Interferon and Cytokine
Research. – 2000. – Vol. 20 (12). – P. 1039-1047.
99. Dennesen P.J. Resolution of infectious parameters after antimicrobial therapy in patients
with ventilator-associated pneumonia / P.J. Dennesen, A.J. Van der Ven, A.G. Kessels
[et al.] // Am. J. Respir. Crit. Care Med. – 2001. – Vol. 163 (6). – P. 1371-1374.
100. Echchannaoui H. CD14 deficiency leads to increased MIP-2 production, CXCR2
expression, neutrophil transmigration, and early death in pneumococcal infection / H.
Echchannaoui, K. Frei, M. Letiembre [et al.] // J. Leukoc. Biol. – 2005. – Vol. 78. – P.
705-715.
101. Eng H.-L. Association of CD14 promoter gene polymorphism and Chlamydia
pneumoniae infection / H.-L. Eng, C.-H. Chen, C.-C. Kuo [et al.] // J. Infect. Dis. – 2003.
– Vol. 188. – P. 90-97.
102. Eng H.-L. A CD14 promoter polymorphism is associated with CD14 expression
and Chlamydia - stimulated TNF alpha production / H.-L. Eng, C.-H. Wang, C.-H. Chen
[et al.] // Genes. Immun. – 2004. – Vol. 5. – P. 426-430.